Pre-commercial biotech companies with large market caps in the U.S. 2017

This statistic depicts the market capitalization of pre-commercial biotechnology companies in the United States that have reached over one billion U.S. dollars as of March 2017. At this time, Puma Biotechnology had a market capitalization of 1.38 billion U.S. dollars.

Pre-commercial U.S. biotech companies with large market capitalization as of March 2017 (in million U.S. dollars)*

Market capitalization in million U.S. dollars
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

2017

Region

United States

Survey time period

as of March 31, 2017

Supplementary notes

* Market capitalization over 1 billion U.S. dollars.
** Companies that listed on public markets in 2015 or 2016.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Biotech industry"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.